Girls homozygous for an IL-2–inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation
Authors:
- Oliver FeyenOFOliver Feyen
- Tim NiehuesTNTim Niehues
- Franz RüschendorfFRFranz Rüschendorf
- Norbert HübnerNHNorbert Hübner
- Hans-Jürgen LawsHLHans-Jürgen Laws
- Tanja TeliepsTTTanja Telieps
- Stefan KnappStefan Knapp
- Hans-Heinrich WackerHWHans-Heinrich Wacker
- Alfons MeindlAMAlfons Meindl
- Hassan JumaaHJHassan Jumaa
- Arndt BorkhardtArndt Borkhardt
Open Access
- 1 May 2009
- journal article
- case report
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 119 (5) , 1350-1358
Abstract
The fatal immune dysregulation that sometimes follows EBV infection in boys has been linked to mutations in two X chromosome–encoded genes, SLAM-associated protein (SAP) and X-linked inhibitor of apoptosis (XIAP). In this study we describe 2 girls from a consanguineous Turkish family who died after developing severe immune dysregulation and therapy-resistant EBV-positive B cell proliferation following EBV infection. SNP array–based genome-wide linkage analysis revealed IL-2–inducible T cell kinase (ITK) as a candidate gene for this immunodeficiency syndrome. Both girls harbored a homozygous missense mutation that led to substitution of a highly conserved residue (R335W) in the SH2 domain of ITK. Characteristics of ITK deficiency in mouse models, such as absence of NKT cells and high levels of eomesodermin in CD8+ cells, were seen in either one or both of the girls. Two lines of evidence suggested that R335W caused instability of the ITK protein. First, in silico modeling of the mutant protein predicted destabilization of the SH2 domain. Additionally, Western blot analysis revealed that, unlike wild-type ITK, the R335W mutant was nearly undetectable when expressed in 293 T cells. Our results suggest that ITK deficiency causes what we believe to be a novel immunodeficiency syndrome that leads to a fatal inadequate immune response to EBV. Because ITK deficiency resembles EBV-associated lymphoproliferative disorders in boys, we suggest that this molecular cause should be considered during diagnosis and treatment.Keywords
This publication has 39 references indexed in Scilit:
- ITK and IL-15 support two distinct subsets of CD8+T cellsProceedings of the National Academy of Sciences, 2006
- The Tec Family Tyrosine Kinases Itk and Rlk Regulate the Development of Conventional CD8+ T CellsImmunity, 2006
- Altered Development of CD8+ T Cell Lineages in Mice Deficient for the Tec Kinases Itk and RlkImmunity, 2006
- Molecular Details of Itk Activation by Prolyl Isomerization and Phospholigand Binding: The NMR Structure of the Itk SH2 Domain Bound to a PhosphopeptideJournal of Molecular Biology, 2006
- TEC FAMILY KINASES IN T LYMPHOCYTE DEVELOPMENT AND FUNCTIONAnnual Review of Immunology, 2005
- TEC-family kinases: regulators of T-helper-cell differentiationNature Reviews Immunology, 2005
- Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene productJournal of Experimental Medicine, 2005
- ALOHOMORA: a tool for linkage analysis using 10K SNP array dataBioinformatics, 2005
- Merlin—rapid analysis of dense genetic maps using sparse gene flow treesNature Genetics, 2001
- The X-Linked Lymphoproliferative Disease: From Autopsy Toward Cloning the Gene 1975–1990Pediatric Pathology, 1991